Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan:46:12-30.
doi: 10.1016/j.bpobgyn.2017.10.004. Epub 2017 Oct 16.

Benign and malignant pathology of the uterus

Affiliations
Review

Benign and malignant pathology of the uterus

V Tanos et al. Best Pract Res Clin Obstet Gynaecol. 2018 Jan.

Erratum in

Abstract

The diagnosis of a uterine myoma size and location can be very precise when a 3D sonograph and knowledge are available. The majority of fibroids are asymptomatic, and expectant management is recommended. In young patients, fibroids cause infertility and in middle-aged women, abnormal uterine bleedings. Laparoscopic myomectomy is the preferred way of surgery for IM and SS fibroids, versus hysteroscopy for SM fibroids. In both cases, the size, number of fibroids and the surgeon's experience determine the limitations of the MIGS. Medical treatments provide only temporary tumor reduction and symptom alleviation. Leiomyosarcoma risk is higher in older women usually carrying fibroids larger than 8 cm. There are no other pathognomonic parameters ruling out a sarcoma. In case of suspected fibroid malignancy, the best treatment option is laparotomy and total hysterectomy. Myomectomy complications can be reduced when MIGS is performed by a surgeon with proper training and experience.

Keywords: Hysteroscopic myomectomy; Imaging; Laparoscopic myomectomy; Myoma and infertility; Uterine fibroid; Uterine sarcoma.

PubMed Disclaimer

Similar articles

  • The management of uterine fibroids in women with otherwise unexplained infertility.
    Carranza-Mamane B, Havelock J, Hemmings R; REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY COMMITTEE; SPECIAL CONTRIBUTOR. Carranza-Mamane B, et al. J Obstet Gynaecol Can. 2015 Mar;37(3):277-285. doi: 10.1016/S1701-2163(15)30318-2. J Obstet Gynaecol Can. 2015. PMID: 26001875
  • The management of uterine leiomyomas.
    Vilos GA, Allaire C, Laberge PY, Leyland N; SPECIAL CONTRIBUTORS. Vilos GA, et al. J Obstet Gynaecol Can. 2015 Feb;37(2):157-178. doi: 10.1016/S1701-2163(15)30338-8. J Obstet Gynaecol Can. 2015. PMID: 25767949
  • The management of uterine leiomyomas.
    Lefebvre G, Vilos G, Allaire C, Jeffrey J, Arneja J, Birch C, Fortier M, Wagner MS; Clinical Practice Gynaecology Committee, Society for Obstetricians and Gynaecologists of Canada. Lefebvre G, et al. J Obstet Gynaecol Can. 2003 May;25(5):396-418; quiz 419-22. J Obstet Gynaecol Can. 2003. PMID: 12738981
  • Therapeutic management of uterine fibroid tumors: updated French guidelines.
    Marret H, Fritel X, Ouldamer L, Bendifallah S, Brun JL, De Jesus I, Derrien J, Giraudet G, Kahn V, Koskas M, Legendre G, Lucot JP, Niro J, Panel P, Pelage JP, Fernandez H; CNGOF (French College of Gynecology and Obstetrics). Marret H, et al. Eur J Obstet Gynecol Reprod Biol. 2012 Dec;165(2):156-64. doi: 10.1016/j.ejogrb.2012.07.030. Epub 2012 Aug 29. Eur J Obstet Gynecol Reprod Biol. 2012. PMID: 22939241 Review.
  • Ultrasound diagnosis of uterine myomas.
    Fascilla FD, Cramarossa P, Cannone R, Olivieri C, Vimercati A, Exacoustos C. Fascilla FD, et al. Minerva Ginecol. 2016 Jun;68(3):297-312. Epub 2016 Mar 25. Minerva Ginecol. 2016. PMID: 27014801 Review.

Cited by

MeSH terms

LinkOut - more resources